Tobin Strom1, Arash O Naghavi1, Jane L Messina2,3, Sungjune Kim1, Javier F Torres-Roca1, Jeffery Russell4, Vernon K Sondak2,5, Tapan A Padhya4, Andy M Trotti1, Jimmy J Caudell1, Louis B Harrison1. 1. Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 2. Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 3. Departments of Pathology & Cell Biology and Dermatology, University of South Florida Morsani College of Medicine, Tampa, Florida. 4. Department of Head and Neck and Endocrine Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 5. Departments of Oncologic Sciences and Surgery, University of South Florida Morsani College of Medicine, Tampa, Florida.
Abstract
BACKGROUND: We hypothesized that radiotherapy (RT) would improve both local and regional control with Merkel cell carcinoma of the head and neck. METHODS: A single-institution institutional review board-approved study was performed including 113 patients with nonmetastatic Merkel cell carcinoma of the head and neck. Postoperative RT was delivered to the primary tumor bed (71.7% cases) ± draining lymphatics (33.3% RT cases). RESULTS: Postoperative local RT was associated with improved local control (3-year actuarial local control 89.4% vs 68.1%; p = .005; Cox hazard ratio [HR] 0.18; 95% confidence interval [CI] = 0.06-0.55; p = .002). Similarly, regional RT was associated with improved regional control (3-year actuarial regional control 95.0% vs 66.7%; p = .008; Cox HR = 0.09; 95% CI = 0.01-0.69; p = .02). Regional RT played an important role for both clinical node-negative patients (3-year regional control 100% vs 44.7%; p = .03) and clinical/pathological node-positive patients (3-year regional control 90.9% vs 55.6%; p = .047). CONCLUSION: Local RT was beneficial for all patients with Merkel cell carcinoma of the head and neck, whereas regional RT was beneficial for clinical node-negative and clinical/pathological node-positive patients.
BACKGROUND: We hypothesized that radiotherapy (RT) would improve both local and regional control with Merkel cell carcinoma of the head and neck. METHODS: A single-institution institutional review board-approved study was performed including 113 patients with nonmetastatic Merkel cell carcinoma of the head and neck. Postoperative RT was delivered to the primary tumor bed (71.7% cases) ± draining lymphatics (33.3% RT cases). RESULTS: Postoperative local RT was associated with improved local control (3-year actuarial local control 89.4% vs 68.1%; p = .005; Cox hazard ratio [HR] 0.18; 95% confidence interval [CI] = 0.06-0.55; p = .002). Similarly, regional RT was associated with improved regional control (3-year actuarial regional control 95.0% vs 66.7%; p = .008; Cox HR = 0.09; 95% CI = 0.01-0.69; p = .02). Regional RT played an important role for both clinical node-negative patients (3-year regional control 100% vs 44.7%; p = .03) and clinical/pathological node-positive patients (3-year regional control 90.9% vs 55.6%; p = .047). CONCLUSION: Local RT was beneficial for all patients with Merkel cell carcinoma of the head and neck, whereas regional RT was beneficial for clinical node-negative and clinical/pathological node-positive patients.
Authors: Sungjune Kim; Evan Wuthrick; Dukagjin Blakaj; Zeynep Eroglu; Claire Verschraegen; Ram Thapa; Matthew Mills; Khaled Dibs; Casey Liveringhouse; Jeffery Russell; Jimmy J Caudell; Ahmad Tarhini; Joseph Markowitz; Kari Kendra; Richard Wu; Dung-Tsa Chen; Anders Berglund; Lauren Michael; Mia Aoki; Min-Hsuan Wang; Imene Hamaidi; Pingyan Cheng; Janis de la Iglesia; Robbert J Slebos; Christine H Chung; Todd C Knepper; Carlos M Moran-Segura; Jonathan V Nguyen; Bradford A Perez; Trevor Rose; Louis Harrison; Jane L Messina; Vernon K Sondak; Kenneth Y Tsai; Nikhil I Khushalani; Andrew S Brohl Journal: Lancet Date: 2022-09-12 Impact factor: 202.731
Authors: Maclean M Cook; Stephanie K Schaub; Peter H Goff; Alex Fu; Song Y Park; Daniel S Hippe; Jay J Liao; Smith Apisarnthanarax; Shailender Bhatia; Yolanda D Tseng; Paul T Nghiem; Upendra Parvathaneni Journal: Adv Radiat Oncol Date: 2020-07-21
Authors: Christopher K Bichakjian; Thomas Olencki; Sumaira Z Aasi; Murad Alam; James S Andersen; Rachel Blitzblau; Glen M Bowen; Carlo M Contreras; Gregory A Daniels; Roy Decker; Jeffrey M Farma; Kris Fisher; Brian Gastman; Karthik Ghosh; Roy C Grekin; Kenneth Grossman; Alan L Ho; Karl D Lewis; Manisha Loss; Daniel D Lydiatt; Jane Messina; Kishwer S Nehal; Paul Nghiem; Igor Puzanov; Chrysalyne D Schmults; Ashok R Shaha; Valencia Thomas; Yaohui G Xu; John A Zic; Karin G Hoffmann; Anita M Engh Journal: J Natl Compr Canc Netw Date: 2018-06 Impact factor: 12.693
Authors: Seesha R Takagishi; Tessa E Marx; Christopher Lewis; Erica S Tarabadkar; Ilsa D Juhlin; Astrid Blom; Jayasri G Iyer; Jay J Liao; Yolanda D Tseng; Teresa Fu; Paul Nghiem; Upendra Parvathaneni Journal: Adv Radiat Oncol Date: 2016-10-20
Authors: Erica S Tarabadkar; Teresa Fu; Kristina Lachance; Daniel S Hippe; Thomas Pulliam; Hannah Thomas; Janet Y Li; Christopher W Lewis; Coley Doolittle-Amieva; David R Byrd; Jeremy T Kampp; Upendra Parvathaneni; Paul Nghiem Journal: J Am Acad Dermatol Date: 2020-07-22 Impact factor: 11.527